No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Fuan Pharmaceutical (Group) Co., Ltd. is a comprehensive pharmaceutical enterprise that, along with its subsidiaries, undertakes the research, development, manufacturing, and commercialization of pharmaceutical products across the People's Republic of China. Its product portfolio spans intermediate compounds, active pharmaceutical ingredients (APIs), and finished drug formulations. These formulations cater to a range of therapeutic categories, including anti-infective agents, cardiovascular medications, digestive system remedies, and various other medical products. The group was founded in 2004 and is headquartered in Chongqing, China. It adopted its current name, Fuan Pharmaceutical (Group) Co., Ltd., in August 2013, having previously been known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd.
www.fapharm.comNo one on the platform currently holds 300194.SZ.
No tracked institution reports a position in 300194.SZ as of their last filing.
No one on the platform has traded 300194.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300194.SZFuan Pharmaceutical (Group) Co., Ltd. | $3.76 | +0.27% | $4.5B | — |
| 002349.SZJinghua Pharmaceutical Group Co., Ltd. | $8.02 | -2.08% | $6.7B | — |
| 002393.SZTianjin Lisheng Pharmaceutical Co.,Ltd. | $13.41 | -0.30% | $4.1B | — |
| 002688.SZJinhe Biotechnology Co. Ltd. | $5.14 | +1.38% | $4.0B | — |
| 002728.SZTeyi Pharmaceutical Group Co.,Ltd | $9.11 | -0.00% | $4.7B | — |
| 600351.SSYabao Pharmaceutical Group Co., Ltd | $6.58 | -0.60% | $4.6B | — |
| 600829.SSHPGC Renmintongtai Pharmaceutical Corporation | $9.40 | +1.51% | $5.5B | — |
Source: Financial Modeling Prep · peers by sector/industry